Adverse Effects of IV Albumin Administration

Common Adverse Events

• Fluid overload and pulmonary edema are significant risks, especially in patients with compromised cardiac or pulmonary function, with the American Thoracic Society noting these risks 1
• Hypotension and tachycardia can occur despite albumin being used to treat hypovolemia, as reported by the American College of Chest Physicians 2
• Hemodilution may require RBC transfusion to correct, according to the American Association for the Study of Liver Diseases 3
• Anaphylactic/allergic reactions, including rash, pruritus, rigors, and pyrexia, can occur, as warned by the American Gastroenterological Association 4

Risk Factors for Adverse Events

• Patients with cirrhosis are at higher risk for adverse effects due to increased capillary permeability and compromised lymphatic drainage capacity, as noted by the American Association for the Study of Liver Diseases 5

Specific Complications by Patient Population

Critical Care Patients

• Albumin administration may not be effective for first-line volume replacement and can lead to adverse effects, as reported by the Society of Critical Care Medicine 3, 1

Patients with Cirrhosis

• Higher rates of pulmonary edema are observed in cirrhotic patients receiving albumin for extraperitoneal infections, according to the American Association for the Study of Liver Diseases 5
• Circulatory overload is more common in patients with cirrhosis receiving albumin versus crystalloid, as noted by the European Association for the Study of the Liver 5

Dose-Related Considerations

• Adverse events are generally dose-dependent, with higher doses carrying greater risk, as reported by the American Gastroenterological Association 4

Monitoring Recommendations

• Monitoring for signs of fluid overload, such as respiratory distress, pulmonary rales, and peripheral edema, is recommended by the American College of Chest Physicians 2
• Watching for hypotension and tachycardia during infusion is advised by the American College of Chest Physicians 2
• Being vigilant for signs of allergic reactions, such as skin changes, fever, and rigors, is recommended by the American Gastroenterological Association 4

Practical Considerations

• The cost of albumin should be weighed against potential risks, as noted by the American College of Chest Physicians 3, 1
• Addressing the underlying cause of hypoalbuminemia rather than simply infusing albumin is generally recommended by the American College of Physicians 2

Albumin Contraindications in Hypernatremia, Hypokalemia, and Metabolic Alkalosis

Guideline Recommendations

• The 2024 International Collaboration for Transfusion Medicine Guidelines issue a conditional recommendation (moderate certainty) against using albumin for first‑line volume replacement in critically ill adults or for correcting low serum albumin levels. 6

Clinical Contraindications

• Albumin administration is not indicated for patients presenting with hypernatremia, hypokalemia, and metabolic alkalosis; it can exacerbate fluid overload and worsen hypernatremia. 6
• Albumin has no therapeutic role in correcting electrolyte disturbances such as hypokalemia or acid‑base disorders like metabolic alkalosis. 6

Practical Management Advice

• Clinicians should avoid using albumin as a volume expander in this clinical setting because it does not address the underlying electrolyte or acid‑base abnormalities and carries significant risk of fluid overload. 6
• The presence of hypoalbuminemia does not mandate albumin replacement; the underlying cause of protein loss should be identified and treated instead of infusing albumin. 6